Anticoagulants are considered to be more effective than antiplatelet agents like aspirin in reducing the risk of stroke and systemic embolism in patients with AF (atrial fibrillation). However, both types of medications have been associated with the risk of bleeding and hemorrhage.
@krieghI Moulton, I mean what the best choice is,due to maintaing the balance between the risk of bleeding and thromboembolic events, the correct administration of antiplatelet and anticoagulation is high challenging among physicians.
@Kriegh Moulton, I need a clinical-based evidence reply. OAC monotherapy? SAPT+DOAC????
There is NO one best choice. It's all based on patient characteriistics, enabling us to tailor a treatment to the individual. What you need is a copy of the guidelines and I'll attach it. It's not a black-and-white world out there.
I am struck by the broad nature of some of the questions found on Research Gate. Many can be answered by Google. I think Research Gate is designed more for answers to esoteric research questions. Some of these questions actually sound as if someone is repeating a test question that they are trying to get an answer to.
- Badges
- Science topic